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To the Editor: Doxycycline is an effective antimalar-
ial prophylactic drug when administered as a monotherapy 
1 day before, daily during, and for 4 weeks after travel 
to an area where malaria is endemic (1). Doxycycline is 
currently a recommended chemoprophylactic regimen for 
travelers visiting areas where malaria is endemic and has 
a high prevalence of chloroquine or multidrug resistance 
(2). The World Health Organization also recommends 
doxycycline in combination with quinine or artesunate as 
the second-line treatment for uncomplicated Plasmodium 
falciparum malaria (3).
Prophylactic and clinical failures of doxycycline against 
P. falciparum have been associated with both inadequate 
doses (4) and poor patient compliance (5). However, resis-
tance can also explain failures of prophylaxis. Cycline re-
sistance in Plasmodium spp. has been documented as a con-
sequence of selective drug pressure in a P. berghei murine 
malaria model (6). The administration of increasing doses 
of minocycline to mice infected with 1 × 107 parasites for 86 
successive passages over 600 days made it possible to obtain 
a resistant P. berghei strain with a median drug inhibitory 
concentration (IC50) of 600 mg/kg/d, which is 6-fold higher 
than that of the susceptible starting strain (100 mg/kg/d) (6). 
A Bayesian mixture modeling approach identified 3 differ-
ent phenotypes (low, medium, and high doxycycline IC50 
phenotypic groups) among P. falciparum clinical isolates 
(7,8). Using 90 isolates from 14 countries, we demonstrated 
that increases in copy numbers of P. falciparum metabolite 
drug transporter gene (Pfmdt, PFE0825w) and P. falciparum 
GTPase TetQ gene (PfTetQ, PFL1710c) are associated with 
reduced susceptibility to doxycycline (9); this association 
was later confirmed (7). In addition, isolates with PfTetQ 
KYNNNN motif repeats are associated with in vitro reduced 
susceptibility to doxycycline and with a significantly higher 
probability of having an IC50 above the doxycycline resis-
tance threshold of 35 mM (9,10).
We report a case of documented malaria prophylac-
tic failure with doxycycline in a 26-year-old soldier from 
France who was infected during a 6-week peacekeeping 
mission in the Central African Republic in 2014. According 
to his colleagues and the collective prophylaxis intake, the 
patient had been compliant with doxycycline prophylaxis. 
On admission to a hospital in Bangui, Central African Re-
public, the patient had fever (temperature 40°C), alteration 
of consciousness, and hypotension. The diagnosis of severe 
P. falciparum malaria was made on the basis of a rapid diag-
nostic test confirmed by a blood smear test (parasitemia 8% 
on day 0). Intravenous artesunate was immediately started, 
in accordance with World Health Organization recommen-
dations (3). The patient’s clinical condition worsened, and 
kidney failure developed. Twenty-four hours later (day 1), 
he was transported by airplane to Bégin Military Teach-
ing Hospital (Saint-Mandé, France). On admission, he had 
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cerebral edema and a P. falciparum parasitemia level of 
0.7%. The patient died 1 day later (day 2).
A blood sample obtained from the patient on day 1 in 
France showed a doxycycline concentration of 195 µg/mL 
plasma. This concentration, which was determined by liquid 
chromatography coupled with tandem mass spectrometry, 
was compatible with a last doxycycline uptake 1 day before 
diagnosis (day –1). The finding of the expected doxycycline 
plasma concentration, together with assurances (colleague’s 
statements and collective intake of doxycycline) that the pa-
tient had followed the drug regimen, was sufficient to sug-
gest prophylaxis failure in a treatment-compliant patient. 
The P. falciparum sample obtained from the patient on 
arrival in France was evaluated for in vitro susceptibility 
to doxycycline, but the evaluation was unsuccessful. The 
number of copies of PfTetQ and Pfmdt genes were evalu-
ated relative to the single-copy P. falciparum b-tubulin 
gene (pfβtubulin), as previously described (7,8). The sam-
ple was assayed in triplicate. The 2–ΔΔCt method (where Ct 
indicates cycle threshold) of relative quantification was 
used and adapted to estimate the number of copies of Pfmdt 
and PfTetQ by using the formula DDCt = (Ct (PfTetQ or Pfmdt) 
–Ct (Pfβtubulin))Sample –(Ct (PfTetQ or Pfmdt) –Ct (Pfβtubulin))Calibrator. 
Genomic DNA extracted from 3D7 P. falciparum, which has 
a single copy of each gene, was used for calibrator sample; 
Pfβtubulin served as the control housekeeping gene. The 
experiment was assayed twice. The sample had 2 copies 
of PfTetQ and Pfmdt genes, which suggested decreased in 
vitro susceptibility of the sample to doxycycline (8,9). The 
genotyping of PfTetQ sequence polymorphisms was done 
by using conventional methods with the primers PfTetQ 
forward (5'-TCACGACAAATGTGCTAGATAC-3') and 
PfTetQ reverse (5'-ATCATCATTTGTGGTGGATAT-3'), 
as previously described (10). Two PfTetQ KYNNNN mo-
tif repeats were found in the sample; <3 KYNNNN motif 
repeats are predictive of in vitro P. falciparum–resistant 
parasites with an IC50 of >35 mM (odds ratio 15) (10). The 
2 copies of Pfmdt and the 2 KYNNNN motif repeats have 
been shown to be associated with parasites with in vitro 
resistance to doxycycline (9,10). The association of doxy-
cycline resistance (prophylactic failure with statement of 
correct intake and the presence of an expected concentra-
tion) with increased Pfmdt copies and decreased PfTetQ 
KYNNNN motif repeats suggest that these molecular 
markers are predictive markers of doxycycline resistance 
that can be used for resistance surveillance.
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